Jan Korniluk

Warsaw, MZ 04141, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study.

Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study.

Journal: BMC cancer
Published: June 14, 2020

Metastatic Tumor Burden and Loci as Predictors of First Line Sunitinib Treatment Efficacy in Patients with Renal Cell Carcinoma.

Metastatic Tumor Burden and Loci as Predictors of First Line Sunitinib Treatment Efficacy in Patients with Renal Cell Carcinoma.

Journal: Scientific reports
Published: September 26, 2018

The Predictive Value of SPECT/CT imaging in colorectal liver metastases response after 90Y-radioembolization.

The Predictive Value of SPECT/CT imaging in colorectal liver metastases response after 90Y-radioembolization.

Journal: PloS one
Published: January 19, 2018

Long-term response to sunitinib: everolimus treatment in metastatic clear cell renal cell carcinoma.

Long-term response to sunitinib: everolimus treatment in metastatic clear cell renal cell carcinoma.

Journal: Future oncology (London, England)
Published: September 07, 2016

Feasibility, efficacy and safety of tyrosine kinase inhibitor treatment in hemodialyzed patients with renal cell cancer: 10 years of experience.

Feasibility, efficacy and safety of tyrosine kinase inhibitor treatment in hemodialyzed patients with renal cell cancer: 10 years of experience.

Journal: Future oncology (London, England)
Published: August 12, 2015

The use of 90Y-PET imaging in evaluation of 90Y-microspheres distribution in the liver: initial results.

The use of 90Y-PET imaging in evaluation of 90Y-microspheres distribution in the liver: initial results.

Journal: Nuclear medicine review. Central & Eastern Europe
Published: July 31, 2015

Mutation of the PIK3CA gene as a prognostic factor in patients with colorectal cancer.

Mutation of the PIK3CA gene as a prognostic factor in patients with colorectal cancer.

Journal: Oncology letters
Published: July 17, 2014

Prolonged complete response following gemcitabine-erlotinib combined therapy in advanced pancreatic cancer.

Prolonged complete response following gemcitabine-erlotinib combined therapy in advanced pancreatic cancer.

Journal: Oncology letters
Published: April 06, 2014

Mitomycin C and high-dose 5-fluorouracil with folinic acid as a therapeutic option for heavily pretreated patients with metastatic colorectal cancer: prospective phase II trial.

Mitomycin C and high-dose 5-fluorouracil with folinic acid as a therapeutic option for heavily pretreated patients with metastatic colorectal cancer: prospective phase II trial.

Journal: The oncologist
Published: April 01, 2014

Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system.

Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system.

Journal: OncoTargets and therapy
Published: August 09, 2013

K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy.

K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy.

Journal: Cancer biology & therapy
Published: August 23, 2012
Showing 1-11 of 11

Last Updated: 09/26/2026